SCHEMBL2882386

SCHEMBL2882386

Cc1cc(N2CCN(CCCCC(N)C(=O)N3CCSC3)CC2)c2ccccc2n1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 7/20 0.52
NCF1 P14598 5/20 0.50
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 1/20 0.46
DPP7 Q9UHL4 4/20 0.45
DPP8 Q6V1X1 2/20 0.45
DPP9 Q86TI2 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.42
USP2 O75604 1/20 0.42
LMNA P02545 1/20 0.42
PKM P14618 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
DRD2 P14416 1/20 0.41
DRD3 P35462 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2882381 1.00 DPP4 (0.52) DPP4NCF1MEN1KMT2AMAPT
SCHEMBL2849859 0.88 DPP4 (0.44) DPP4NCF1DPP7DPP8DPP9
SCHEMBL2849863 0.88 DPP4 (0.44) DPP4NCF1DPP7DPP8DPP9
Hydrochloric Acid SCHEMBL2850456 0.87 DRD2 (0.56) DPP4NCF1MAPTDPP7DPP8
Hydrochloric Acid SCHEMBL2850459 0.87 DRD2 (0.56) DPP4NCF1MAPTDPP7DPP8
SCHEMBL2863109 0.85 KCNH2 (0.53) DPP4DPP7DPP8DPP9DRD2
SCHEMBL2863113 0.85 KCNH2 (0.53) DPP4DPP7DPP8DPP9DRD2
SCHEMBL2854187 0.81 DPP4 (0.48) DPP4MEN1KMT2ADPP7DPP8
SCHEMBL2854189 0.81 DPP4 (0.48) DPP4MEN1KMT2ADPP7DPP8
SCHEMBL2855721 0.80 AKT1 (0.55) DPP4DPP7DPP8DPP9DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790725-B2 Thiazolidine derivatives and medicinal use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-09-07 US disclosed
US-20070259880-A1 THIAZOLIDINE DERIVATIVES AND MEDICINAL USE THEREOF MITSUBISHI PHARMA CORPORATION (JP) 2007-11-08 US disclosed
CN-1606549-A Thiazolidine derivative and medical application thereof MITSUBISHI PHARMA CORP (JP) 2005-04-13 CN disclosed
US-20040259883-A1 Thiazolidine derivative and medicinal use thereof MITSUBISHI PHARMA CORPORATION (JP) 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259880-A1 THIAZOLIDINE DERIVATIVES AND MEDICINAL USE THEREOF DPP4, DPP7, DPP3 DPP4 1/4885NCF1 3500/4885MEN1 3295/4885
US-20040259883-A1 Thiazolidine derivative and medicinal use thereof DPP4, DPP7, DPP3 DPP4 1/4885NCF1 3051/4885MEN1 2196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.